ABBV - AbbVie Inc.
Close
178.36
0.245 0.137%
Share volume: 119,600
Last Updated: Wed 08 Jan 2025 08:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.55%
PREVIOUS CLOSE
CHG
CHG%
$178.12
0.25
0.14%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2023-05-05 | 2023-08-07 | 2023-11-06 | 2024-02-20 | 2024-05-03 | |
Assets | ||||||
Total Assets | 134.544 B | 135.367 B | 136.221 B | 134.711 B | 148.874 B | |
Current Assets | 26.488 B | 28.852 B | 33.224 B | 33.002 B | 38.871 B | |
Inventories | 3.833 B | 4.055 B | 3.981 B | 4.099 B | 4.245 B | |
Other Current Assets | 4.460 B | 4.540 B | 4.541 B | 4.932 B | 4.608 B | |
Short Term Investments | 4.460 B | 4.540 B | 4.541 B | 4.932 B | 4.608 B | |
Total Receivables | 11.473 B | 11.491 B | 11.412 B | 11.155 B | 11.949 B | |
Current Cash | 6.722 B | 8.766 B | 13.290 B | 12.816 B | 18.069 B | |
Total Non-current Assets | 108.056 B | 106.515 B | 102.997 B | 101.709 B | 110.003 B | |
Property Plant Equipment | 4.931 B | 4.943 B | 4.934 B | 4.989 B | 4.980 B | |
Other Assets | 5.800 B | 6.198 B | 7.094 B | 8.513 B | 9.067 B | |
Intangible Assets | 64.848 B | 62.862 B | 58.603 B | 55.610 B | 62.225 B | |
Goodwill | 32.220 B | 32.224 B | 32.091 B | 32.293 B | 33.426 B | |
Liabilities and shareholders’ equity | ||||||
Total Liabilities and shareholders’ equity | 134.544 B | 135.367 B | 136.221 B | 134.711 B | 148.874 B | |
Total liabilities | 121.270 B | 122.501 B | 124.127 B | 124.351 B | 140.867 B | |
Total current liabilities | 27.590 B | 32.239 B | 34.773 B | 37.841 B | 41.522 B | |
Accounts Payable | 0.000 | 0.000 | 0.000 | 3.688 B | 0.000 | |
Other liabilities | 32.249 B | 32.294 B | 31.644 B | 32.327 B | 32.778 B | |
Current long term debt | 2.801 B | 5.203 B | 5.115 B | 7.191 B | 10.196 B | |
Long term debt | 59.292 B | 55.812 B | 55.631 B | 52.194 B | 63.805 B | |
Other liabilities | 32.249 B | 32.294 B | 31.644 B | 32.327 B | 32.778 B | |
Minority interest | 29.000 M | 32.000 M | 35.000 M | 37.000 M | 40.000 M | |
Total Shareholder equity | 13.274 B | 12.866 B | 12.094 B | 10.360 B | 8.007 B | |
Common stock | 1.770 B | 1.767 B | 1.767 B | 1.768 B | 1.769 B | |
Retained earnings | 2.393 B | 1.789 B | 933.000 M | -1.000 B | -2.384 B |